22nd Century Group, Inc.

NasdaqCM:XXII Voorraadrapport

Marktkapitalisatie: US$4.4m

22nd Century Group Inkomsten in het verleden

Verleden criteriumcontroles 0/6

22nd Century Group's earnings have been declining at an average annual rate of -26.4%, while the Tobacco industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 0.8% per year.

Belangrijke informatie

-26.4%

Groei van de winst

-3.5%

Groei van de winst per aandeel

Tobacco Groei van de industrie18.1%
Inkomstengroei-0.8%
Rendement op eigen vermogenn/a
Nettomarge-267.7%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Apr 02
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Jun 14
With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Jan 13
Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

Oct 03

Opbrengsten en kosten

Hoe 22nd Century Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqCM:XXII Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2419-51172
31 Mar 2419-63242
31 Dec 2322-65313
30 Sep 2327-101332
30 Jun 2327-41362
31 Mar 2330-38353
31 Dec 2228-37324
30 Sep 2249-47395
30 Jun 2239-44315
31 Mar 2230-36284
31 Dec 2131-33264
30 Sep 2123-25234
30 Jun 2125-20194
31 Mar 2128-21174
31 Dec 2028-20154
30 Sep 2028-20134
30 Jun 2027-26146
31 Mar 2027-29137
31 Dec 1926-27138
30 Sep 1926-291110
30 Jun 1926-13912
31 Mar 1927-11915
31 Dec 1826-8915
30 Sep 1825-3913
30 Jun 1824-1299
31 Mar 1820-995
31 Dec 1717-1383
30 Sep 1714-1283
30 Jun 1713-1173
31 Mar 1711-1172
31 Dec 1612-1282
30 Sep 1612-1282
30 Jun 1611-1282
31 Mar 1611-1082
31 Dec 159-1192
30 Sep 156-14111
30 Jun 153-14121
31 Mar 151-14121
31 Dec 141-1691
30 Sep 148-1861
30 Jun 148-3041
31 Mar 148-2941
31 Dec 137-2641

Kwaliteitswinsten: XXII is currently unprofitable.

Groeiende winstmarge: XXII is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: XXII is unprofitable, and losses have increased over the past 5 years at a rate of 26.4% per year.

Versnelling van de groei: Unable to compare XXII's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: XXII is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (2.3%).


Rendement op eigen vermogen

Hoge ROE: XXII's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden